268 related articles for article (PubMed ID: 35809263)
1. Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy.
Fernando R; Smith TJ
J Clin Endocrinol Metab; 2022 Sep; 107(10):e4037-e4047. PubMed ID: 35809263
[TBL] [Abstract][Full Text] [Related]
2. Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes: Potential Relevance to Thyroid-Associated Ophthalmopathy.
Fernando R; Smith TJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):e20-e33. PubMed ID: 32968816
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy.
Fernando R; Caldera O; Smith TJ
Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34949642
[TBL] [Abstract][Full Text] [Related]
4. Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.
Chen H; Mester T; Raychaudhuri N; Kauh CY; Gupta S; Smith TJ; Douglas RS
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1635-40. PubMed ID: 24878056
[TBL] [Abstract][Full Text] [Related]
5. Slit2 Modulates the Inflammatory Phenotype of Orbit-Infiltrating Fibrocytes in Graves' Disease.
Fernando R; Grisolia ABD; Lu Y; Atkins S; Smith TJ
J Immunol; 2018 Jun; 200(12):3942-3949. PubMed ID: 29752312
[TBL] [Abstract][Full Text] [Related]
6. Slit2 May Underlie Divergent Induction by Thyrotropin of IL-23 and IL-12 in Human Fibrocytes.
Fernando R; Atkins SJ; Smith TJ
J Immunol; 2020 Apr; 204(7):1724-1735. PubMed ID: 32086386
[TBL] [Abstract][Full Text] [Related]
7. Divergent expression of IL-1 receptor antagonists in CD34⁺ fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation.
Li B; Smith TJ
J Clin Endocrinol Metab; 2013 Jul; 98(7):2783-90. PubMed ID: 23633206
[TBL] [Abstract][Full Text] [Related]
8. Increased generation of fibrocytes in thyroid-associated ophthalmopathy.
Douglas RS; Afifiyan NF; Hwang CJ; Chong K; Haider U; Richards P; Gianoukakis AG; Smith TJ
J Clin Endocrinol Metab; 2010 Jan; 95(1):430-8. PubMed ID: 19897675
[TBL] [Abstract][Full Text] [Related]
9. Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE.
Fernando R; Lu Y; Atkins SJ; Mester T; Branham K; Smith TJ
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1236-44. PubMed ID: 24708100
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production.
Gillespie EF; Papageorgiou KI; Fernando R; Raychaudhuri N; Cockerham KP; Charara LK; Goncalves AC; Zhao SX; Ginter A; Lu Y; Smith TJ; Douglas RS
J Clin Endocrinol Metab; 2012 May; 97(5):E740-6. PubMed ID: 22399514
[TBL] [Abstract][Full Text] [Related]
11. CD34- Orbital Fibroblasts From Patients With Thyroid-Associated Ophthalmopathy Modulate TNF-α Expression in CD34+ Fibroblasts and Fibrocytes.
Lu Y; Atkins SJ; Fernando R; Trierweiler A; Mester T; Grisolia ABD; Mou P; Novaes P; Smith TJ
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2615-2622. PubMed ID: 29847668
[TBL] [Abstract][Full Text] [Related]
12. Regulation of IL-1 receptor antagonist by TSH in fibrocytes and orbital fibroblasts.
Li B; Smith TJ
J Clin Endocrinol Metab; 2014 Apr; 99(4):E625-33. PubMed ID: 24446657
[TBL] [Abstract][Full Text] [Related]
13. Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy.
Ding Y; Yang S; Gao H
Horm Metab Res; 2021 Apr; 53(4):211-218. PubMed ID: 33853117
[TBL] [Abstract][Full Text] [Related]
14. Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.
Smith TJ; Padovani-Claudio DA; Lu Y; Raychaudhuri N; Fernando R; Atkins S; Gillespie EF; Gianoukakis AG; Miller BS; Gauger PG; Doherty GM; Douglas RS
J Clin Endocrinol Metab; 2011 Dec; 96(12):3827-37. PubMed ID: 21956421
[TBL] [Abstract][Full Text] [Related]
15. Human fibrocytes coexpress thyroglobulin and thyrotropin receptor.
Fernando R; Atkins S; Raychaudhuri N; Lu Y; Li B; Douglas RS; Smith TJ
Proc Natl Acad Sci U S A; 2012 May; 109(19):7427-32. PubMed ID: 22517745
[TBL] [Abstract][Full Text] [Related]
16. 2021 update on thyroid-associated ophthalmopathy.
Neag EJ; Smith TJ
J Endocrinol Invest; 2022 Feb; 45(2):235-259. PubMed ID: 34417736
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions.
Raychaudhuri N; Fernando R; Smith TJ
PLoS One; 2013; 8(9):e75100. PubMed ID: 24086448
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis).
Douglas RS; Mester T; Ginter A; Kim DS
Trans Am Ophthalmol Soc; 2014; 112():26-37. PubMed ID: 25411513
[TBL] [Abstract][Full Text] [Related]
19. Fibrocyte Participation in Thyroid-Associated Ophthalmopathy Suggests New Approaches to Therapy.
Smith TJ
Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S9-S18. PubMed ID: 38054981
[TBL] [Abstract][Full Text] [Related]
20. Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.
Smith TJ
J Clin Endocrinol Metab; 2019 Feb; 104(2):581-594. PubMed ID: 30445529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
